|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Product sales, net | |||||
| Total product sales, net | |||||
| License fees and collaboration revenue | |||||
| Total revenues | |||||
| Operating expenses: | |||||
| Cost of sales | |||||
| Product sales, net | |||||
| License fees and collaboration revenue | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Total operating expenses | |||||
| Loss from operations before other income (expense) | |||||
| Other income (expense): | |||||
| Interest income | |||||
| Interest expense | |||||
| Loss on debt extinguishment | |||||
| Other income (expense), net | |||||
| Realized/unrealized (loss) gain on equity investments | |||||
| Change in fair value of equity warrants issued by licensee | |||||
| Total other income, net | |||||
| Loss before income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Unrealized gain (loss) on marketable securities and cash equivalents | |||||
| Comprehensive loss | |||||
| Net loss per share, basic (usd per share) | |||||
| Net loss per share, diluted (usd per share) | |||||
| Weighted-average shares outstanding, basic (in shares) | |||||
| Weighted-average shares outstanding, diluted (in shares) | |||||
Loading...